Filter Results:
(54)
Show Results For
- All HBS Web
(636)
- People (2)
- News (54)
- Research (447)
- Events (2)
- Multimedia (9)
- Faculty Publications (391)
Show Results For
- All HBS Web
(636)
- People (2)
- News (54)
- Research (447)
- Events (2)
- Multimedia (9)
- Faculty Publications (391)
Page 1 of 54
Results →
Sort by
- 07 Apr 2016
- News
Sanofi Genzyme Donates Corporate Archives to Harvard Business School
- 03 Aug 2010
- News
Analysis: Rare diseases lure Sanofi, other big drugmakers
- 04 Jun 2010
- News
Another View: Can Biotech Survive Icahn?
- 15 Feb 2011
- News
Who will blink in Genzyme, Sanofi price talks?
- 03 Dec 2012
- News
In World of Big Stuff, the U.S. Still Rules
- 08 Jan 2018
- News
What Do Investors and Companies Talk About?
- 31 Jan 2014
- News
Body, Heal Thyself
Chien and Derrick Rossi, published a paper in the journal Nature Biotechnology that showed mRNA Therapeutics was capable of stimulating blood vessel growth, repairing damaged heart tissue, and helping a mouse through myocardial... View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
focused on patients. “Patients and their families are at the center of why I want to be in the biotechnology space,” she concludes. “When you’re working on rare diseases, it’s hard not to feel like you’re making a difference.” View Details
- 01 Aug 1998
- News
High Honors
education." McDermott hasn't slowed down in retirement, concentrating his energy and vision on an array of community-related projects. Among them is the Texas Research and Technology Foundation, which he established in 1984 to develop San Antonio's Texas Research Park,... View Details
- 01 Apr 2000
- News
Porter's Paradox
decisive, enduring advantages, therefore, become unique local centers of innovation for the likes of mutual funds, venture capital, and biotechnology in Greater Boston or aircraft equipment and design, boat- and shipbuilding, and metal... View Details
- 24 Apr 2014
- News
Offering a breath of life for critically ill patients
Patients suffering from diseases such as inoperable tracheal cancer, or those born without a trachea, have been granted a second chance. As biotechnology and surgical expertise progress, Green foresees a future without waiting lists for... View Details
- 24 Apr 2014
- News
A passion for the sea doubles the percent of ocean set aside for conservation
Ernesto Bertarelli (MBA 1993), an America’s Cup–winning sailor and avid scuba diver, understands the importance of protecting marine ecosystems. The former owner and CEO of the pharmaceutical and biotechnology company Serono has provided... View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift... View Details
Keywords: Anne Kavanagh
- 01 Jun 1998
- News
Short Takes
inextricably intertwined with institutions that are inherently local," he writes. He intends to test his findings by investigating process innovation in companies entering the semiconductor industry from Europe and Asia. He also plans to conduct a similar study of... View Details
Keywords: Orna Feldman and Caroline Chauncey
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
and CEO of Mediconsulting, Inc., spoke about creating a better model for business collaborations between biotech and pharmaceutical firms. Said Klietmann, the conference's biotechnology chair and a lecturer in pathology at Harvard Medical... View Details
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 01 Feb 1999
- News
Classmates Rally to Help Family Stricken with Rare Disease
scientists and researchers, in conjunction with several biotechnology companies, including Genzyme Corp., are now ready to test on humans an enzyme replacement therapy that has been successful in reversing the disease in laboratory... View Details
- 01 Jun 2000
- News
Seeing the Light
Living in Los Angeles and working as a marketer for a global biotechnology firm, Jana Kirlin Brownell (MBA '83) saw her career path take an unexpected turn. More than once, her father had asked her to come home and take over the Kirlin... View Details